Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Dec 15, 2024; 16(12): 4700-4715
Published online Dec 15, 2024. doi: 10.4251/wjgo.v16.i12.4700
Published online Dec 15, 2024. doi: 10.4251/wjgo.v16.i12.4700
Figure 3 The expression of shank-associated RH domain interactor, metalloproteinase inhibitor 1, nucleolar complex protein 2 homolog, and DNA ligase 4 proteins and its association with tumor-node-metastasis and overall survival in colorectal cancer.
A: The expression of 4 proteins among tumor-node-metastasis (TNM) stages in 52 colorectal cancer (CRC) patients; B: The expression of 4 proteins in TCGA; C: The expression of 4 proteins among TNM stages in TCGA; D: The association between expression of 4 proteins and overall survival in TCGA; E: The immunohistochemistry of shank-associated RH domain interactor in 93 CRC tissues and 35 normal tissues. aP < 0.05; bP < 0.01; CRC: Colorectal cancer; HC: Health control; SHARPIN: Shank-associated RH domain interactor; TIMP1: Metalloproteinase inhibitor 1; NOC2 L: Nucleolar complex protein 2 homolog; LIG4: DNA ligase 4.
- Citation: Zhou YC, Wang QQ, Zhou GYJ, Yin TF, Zhao DY, Sun XZ, Tan C, Zhou L, Yao SK. Matrine promotes colorectal cancer apoptosis by downregulating shank-associated RH domain interactor expression. World J Gastrointest Oncol 2024; 16(12): 4700-4715
- URL: https://www.wjgnet.com/1948-5204/full/v16/i12/4700.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i12.4700